1. Emodin inhibits LOVO colorectal cancer cell proliferation via the regulation of the Bcl-2/Bax ratio and cytochrome c
   LIANG MA et al, 2014, Experimental and Therapeutic Medicine CrossRef
2. Fecal occult blood test/fecal carcinoembriogenic antigen dual rapid test as a useful tool for colorectal cancer screening
   Maru Kim et al, 2017, European Surgery CrossRef
3. The fecal occult blood test as a tool for improved outpatient qualification for colonoscopy. A single-center experience and 10-year follow-up survey
   Zbigniew Banaszkiewicz et al, 2017, Advances in Medical Sciences CrossRef
4. Higher satisfaction with an alternative collection device for stool sampling in colorectal cancer screening with fecal immunochemical test: a cross-sectional study
   Hye Young Shin et al, 2018, BMC Cancer CrossRef
5. Colorectal cancer screening; colonoscopy and biopsy results in people undergoing colonoscopy due to positive fecal occult blood test
   Metin Yücel et al, 2024, Turkish Journal of Surgery CrossRef
6. The effect of changing stool collection processes on compliance in nationwide organized screening using a fecal occult blood test (FOBT) in Korea: study protocol for a randomized controlled trial
   Hye Young Shin et al, 2014, Trials CrossRef
7. Tanshinone IIA enhances chemosensitivity of colon cancer cells by suppressing nuclear factor-κB
   YANGQIU BAI et al, 2016, Experimental and Therapeutic Medicine CrossRef
8. Prevention of Colorectal Cancer: The Future Is Now
   Isha N. Ranadive et al, 2014, Current Colorectal Cancer Reports CrossRef
9. Performance of the Fecal Immunochemical Test for Colorectal Cancer Screening Using Different Stool-Collection Devices: Preliminary Results from a Randomized Controlled Trial
   Hye Young Shin et al, 2016, Gut and Liver CrossRef
10. Thymoquinone chemosensitizes colon cancer cells through inhibition of NF-κB
    Lida Zhang et al, 2016, Oncology Letters CrossRef